Analysis of protein isoforms: Can we do it better?

Protein isoforms/splice variants can play important roles in various biological processes and can potentially be used as biomarkers or therapeutic targets/mediators. Thus, there is a need for efficient and, importantly, accurate methods to distinguish and quantify specific protein isoforms. Since protein isoforms can share a high percentage of amino acid sequence homology and dramatically differ in their cellular concentration, the task for accuracy and efficiency in methodology and instrumentation is challenging. The analysis of intact proteins has been perceived to provide a more accurate and complete result for isoform identification/quantification in comparison to analysis of the corresponding peptides that arise from protein enzymatic digestion. Recently, novel approaches have been explored and developed that can possess the accuracy and reliability important for protein isoform differentiation and isoform‐specific peptide targeting. In this review, we discuss the recent development in methodology and instrumentation for enhanced detection of protein isoforms as well as the examples of their biological importance.

[1]  Lars Malmström,et al.  Automated workflow for large-scale selected reaction monitoring experiments. , 2012, Journal of proteome research.

[2]  E. White,et al.  Fibronectin splice variants: Understanding their multiple roles in health and disease using engineered mouse models , 2011, IUBMB life.

[3]  Brian E. Howard,et al.  Towards reliable isoform quantification using RNA-SEQ data , 2009, 2009 IEEE International Conference on Bioinformatics and Biomedicine.

[4]  Masahiko Hoshijima,et al.  Splice variants of enigma homolog, differentially expressed during heart development, promote or prevent hypertrophy. , 2010, Cardiovascular research.

[5]  Yunchun Liu,et al.  Weak anion exchange chromatographic profiling of glycoprotein isoforms on a polymer monolithic capillary. , 2012, Journal of chromatography. A.

[6]  Hong Wang,et al.  Intact-protein based sample preparation strategies for proteome analysis in combination with mass spectrometry. , 2005, Mass spectrometry reviews.

[7]  L. Montuenga,et al.  Alternative Splicing in Lung Cancer , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[8]  Lawrence Steinman,et al.  Nuanced roles of cytokines in three major human brain disorders. , 2008, The Journal of clinical investigation.

[9]  Jeonghoon Lee,et al.  High resolution time-of-flight mass analysis of the entire range of intact singly-charged proteins. , 2011, Analytical chemistry.

[10]  N. Kelleher,et al.  Decoding protein modifications using top-down mass spectrometry , 2007, Nature Methods.

[11]  Fred W. McLafferty,et al.  Top-down identification and characterization of biomolecules by mass spectrometry , 2008, Journal of the American Society for Mass Spectrometry.

[12]  J. Ervasti,et al.  The Actin Gene Family: Function Follows Isoform , 2010, Cytoskeleton.

[13]  Ludovic C. Gillet,et al.  Targeted Data Extraction of the MS/MS Spectra Generated by Data-independent Acquisition: A New Concept for Consistent and Accurate Proteome Analysis* , 2012, Molecular & Cellular Proteomics.

[14]  Gilbert S. Omenn,et al.  Alternative Splice Variants, a New Class of Protein Cancer Biomarker Candidates: Findings in Pancreatic Cancer and Breast Cancer with Systems Biology Implications , 2010, Disease markers.

[15]  Richard D. Smith,et al.  A top-down LC-FTICR MS-based strategy for characterizing oxidized calmodulin in activated macrophages , 2010, Journal of the American Society for Mass Spectrometry.

[16]  Steven M. Patrie,et al.  Sensitive and reproducible intact mass analysis of complex protein mixtures with superficially porous capillary reversed-phase liquid chromatography mass spectrometry. , 2011, Analytical chemistry.

[17]  M. M. Soares,et al.  Splicing variants impact in thyroid normal physiology and pathological conditions. , 2009, Arquivos brasileiros de endocrinologia e metabologia.

[18]  M. Gelfand,et al.  Frequent alternative splicing of human genes. , 1999, Genome research.

[19]  M. Platzer,et al.  Comparison of methods for quantification of subtle splice variants , 2009, Electrophoresis.

[20]  Karen A. Loveland,et al.  LARGE SCALE , 1991 .

[21]  Andreas Tholey,et al.  Tandem mass tag protein labeling for top-down identification and quantification. , 2012, Analytical chemistry.

[22]  N. Heegaard,et al.  Characterization and stability of transthyretin isoforms in cerebrospinal fluid examined by immunoprecipitation and high-resolution mass spectrometry of intact protein. , 2012, Methods.

[23]  J. C. Tran,et al.  Multiplexed size separation of intact proteins in solution phase for mass spectrometry. , 2009, Analytical chemistry.

[24]  J. C. Tran,et al.  Intact proteome fractionation strategies compatible with mass spectrometry , 2011, Expert review of proteomics.

[25]  F. Regnier,et al.  High-performance hydrophobic interaction chromatography of proteins. , 1984, Analytical biochemistry.

[26]  J. Gebler,et al.  Integration of multidimensional chromatographic protein separations with a combined "top-down" and "bottom-up" proteomic strategy. , 2006, Journal of Proteome Research.

[27]  M. J. Chalmers,et al.  Combined top-down and bottom-up mass spectrometric approach to characterization of biomarkers for renal disease. , 2005, Analytical chemistry.

[28]  F. McLafferty,et al.  Top‐down MS, a powerful complement to the high capabilities of proteolysis proteomics , 2007, The FEBS journal.

[29]  Neil L. Kelleher,et al.  Peer Reviewed: Top-Down Proteomics , 2004 .

[30]  D. Black.  Mechanisms of alternative pre-messenger RNA splicing. , 2003, Annual review of biochemistry.

[31]  A. Pandey,et al.  Electron transfer dissociation mass spectrometry in proteomics , 2012, Proteomics.

[32]  U. Rinas,et al.  Recombinant protein purification using gradient-assisted simulated moving bed hydrophobic interaction chromatography. Part I: selection of chromatographic system and estimation of adsorption isotherms. , 2011, Journal of chromatography. A.

[33]  N. Kelleher,et al.  A robust two-dimensional separation for top-down tandem mass spectrometry of the low-mass proteome , 2009, Journal of the American Society for Mass Spectrometry.

[34]  Naoto Minamino,et al.  electron transfer dissociation mass spectrometry , 2012 .

[35]  S. Humphries,et al.  Polymorphisms in the thrombopoietin gene are associated with risk of myocardial infarction at a young age. , 2001, Atherosclerosis.

[36]  N. Kelleher,et al.  Size-sorting combined with improved nanocapillary liquid chromatography-mass spectrometry for identification of intact proteins up to 80 kDa. , 2010, Analytical chemistry.

[37]  N. Kitteringham,et al.  Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[38]  S. Goheen,et al.  Hydrophobic interaction high-performance liquid chromatography of proteins , 1984 .

[39]  J. Pers,et al.  The late news on baff in autoimmune diseases. , 2010, Autoimmunity reviews.

[40]  M. Ladisch,et al.  Hydrophobic interaction chromatography. , 1989, Biotechnology advances.

[41]  B. Garcia.  What does the future hold for top down mass spectrometry? , 2010, Journal of the American Society for Mass Spectrometry.

[42]  Naoyuki Sugiyama,et al.  Human proteome analysis by using reversed phase monolithic silica capillary columns with enhanced sensitivity. , 2012, Journal of chromatography. A.

[43]  Richard D. LeDuc,et al.  Mapping Intact Protein Isoforms in Discovery Mode Using Top Down Proteomics , 2011, Nature.

[44]  A. Reyes,et al.  Depletion of highly abundant proteins in blood plasma by hydrophobic interaction chromatography for proteomic analysis. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[45]  A. Podgornik,et al.  Short monolithic columns as stationary phases for biochromatography. , 2002, Advances in biochemical engineering/biotechnology.

[46]  Xia Guan,et al.  [Optimization of two-dimensional high performance liquid chromatographic columns for highly efficient separation of intact proteins]. , 2010, Se pu = Chinese journal of chromatography.

[47]  John R Yates,et al.  Top down proteomics. , 2013, Analytical chemistry.

[48]  F. McLafferty,et al.  Extending Top-Down Mass Spectrometry to Proteins with Masses Greater Than 200 Kilodaltons , 2006, Science.

[49]  E. White,et al.  New insights into form and function of fibronectin splice variants , 2008, The Journal of pathology.

[50]  X. Zhang,et al.  Intact-protein trapping columns for proteomic analysis in capillary high-performance liquid chromatography. , 2010, Journal of chromatography. A.

[51]  A. Zaika,et al.  p53 Family: Role of Protein Isoforms in Human Cancer , 2011, Journal of nucleic acids.

[52]  B. Balgley,et al.  Effects of chromatography conditions on intact protein separations for top-down proteomics. , 2005, Journal of chromatography. A.

[53]  R. Wolfert,et al.  A precursor form of PSA (pPSA) is a component of the free PSA in prostate cancer serum. , 1997, Urology.

[54]  A. Kornblihtt,et al.  The connection between splicing and cancer , 2006, Journal of Cell Science.

[55]  C. Dinarello,et al.  IL-37: a new anti-inflammatory cytokine of the IL-1 family. , 2011, European cytokine network.

[56]  N. Kelleher,et al.  Analysis of Intact Protein Isoforms by Mass Spectrometry* , 2011, The Journal of Biological Chemistry.

[57]  L. Bracco,et al.  Methods and platforms for the quantification of splice variants' expression. , 2006, Progress in molecular and subcellular biology.

[58]  Gérard Hopfgartner,et al.  High-resolution mass spectrometry for integrated qualitative and quantitative analysis of pharmaceuticals in biological matrices , 2012, Analytical and Bioanalytical Chemistry.

[59]  S. Brenner,et al.  The evolving roles of alternative splicing. , 2004, Current opinion in structural biology.

[60]  W. Gullick,et al.  The Neuregulin Family of Genes and their Multiple Splice Variants in Breast Cancer , 2008, Journal of Mammary Gland Biology and Neoplasia.

[61]  C. Deng,et al.  Comprehensive two‐dimensional separation in coupling of reversed‐phase chromatography with capillary isoelectric focusing followed by MALDI‐MS identification using on‐target digestion for intact protein analysis , 2006, Electrophoresis.

[62]  D. Black,et al.  Alternative RNA splicing in the nervous system , 2001, Progress in Neurobiology.

[63]  Jeffrey L. Wrana,et al.  An Alternative Splicing Switch Regulates Embryonic Stem Cell Pluripotency and Reprogramming , 2011, Cell.

[64]  B. Brinkman,et al.  Splice variants as cancer biomarkers. , 2004, Clinical biochemistry.

[65]  F. Švec,et al.  Recent advances in the control of morphology and surface chemistry of porous polymer‐based monolithic stationary phases and their application in CEC , 2007, Electrophoresis.

[66]  C. Fagerquist,et al.  Induction and identification of disulfide-intact and disulfide-reduced β-subunit of Shiga toxin 2 from Escherichia coli O157:H7 using MALDI-TOF-TOF-MS/MS and top-down proteomics. , 2011, The Analyst.

[67]  F. Švec,et al.  Porous polymer monoliths: an alternative to classical beads. , 2002, Advances in biochemical engineering/biotechnology.

[68]  B. Simons,et al.  Performance characteristics of a new hybrid quadrupole time-of-flight tandem mass spectrometer (TripleTOF 5600). , 2011, Analytical chemistry.

[69]  S. Hanash,et al.  Intact-protein analysis system for discovery of serum-based disease biomarkers. , 2011, Methods in molecular biology.

[70]  F. McLafferty,et al.  Top down characterization of larger proteins (45 kDa) by electron capture dissociation mass spectrometry. , 2002, Journal of the American Chemical Society.

[71]  S. Harper,et al.  Therapeutic potential of inhibitory VEGF splice variants. , 2005, Future oncology.

[72]  D. Baralle,et al.  Splicing in action: assessing disease causing sequence changes , 2005, Journal of Medical Genetics.

[73]  J. Veuthey,et al.  Analysis of peptides and proteins using sub-2 μm fully porous and sub 3-μm shell particles. , 2011, Journal of chromatography. A.

[74]  O. Hansson,et al.  Molecular Function of TCF7L2: Consequences of TCF7L2 Splicing for Molecular Function and Risk for Type 2 Diabetes , 2010, Current diabetes reports.

[75]  M. Anderson,et al.  Automated hydrophobic interaction chromatography column selection for use in protein purification. , 2011, Journal of visualized experiments : JoVE.

[76]  F. Regnier,et al.  Comparison of hydrophobic-interaction and reversed-phase chromatography of proteins. , 1984, Journal of chromatography.

[77]  B. Frey,et al.  Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing , 2008, Nature Genetics.

[78]  M. Gross,et al.  Native electrospray and electron-capture dissociation in FTICR mass spectrometry provide top-down sequencing of a protein component in an intact protein assembly , 2010, Journal of the American Society for Mass Spectrometry.

[79]  R. Aebersold,et al.  Selected reaction monitoring for quantitative proteomics: a tutorial , 2008, Molecular systems biology.

[80]  Fei Wang,et al.  On-line separation of native proteins by two-dimensional liquid chromatography using a single column. , 2009, Journal of chromatography. A.

[81]  M. Romano,et al.  Thrombopoietin and its splicing variants: structure and functions in thrombopoiesis and beyond. , 2008, Biochimica et biophysica acta.

[82]  Hojoong Kim,et al.  Large-scale isotype-specific quantification of Serum amyloid A 1/2 by multiple reaction monitoring in crude sera. , 2012, Journal of proteomics.

[83]  M. Mann,et al.  Ultra High Resolution Linear Ion Trap Orbitrap Mass Spectrometer (Orbitrap Elite) Facilitates Top Down LC MS/MS and Versatile Peptide Fragmentation Modes* , 2011, Molecular & Cellular Proteomics.

[84]  F. Gilli.  Role of differential expression of interferon receptor isoforms on the response of multiple sclerosis patients to therapy with interferon beta. , 2010, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[85]  N. Kelleher,et al.  Nano-LC FTICR tandem mass spectrometry for top-down proteomics: routine baseline unit mass resolution of whole cell lysate proteins up to 72 kDa. , 2012, Analytical chemistry.

[86]  R. Kostiainen,et al.  Microchip capillary electrophoresis-electrospray ionization-mass spectrometry of intact proteins using uncoated Ormocomp microchips. , 2012, Analytica chimica acta.

[87]  R. Shamir,et al.  How prevalent is functional alternative splicing in the human genome? , 2004, Trends in genetics : TIG.

[88]  N. Kelleher,et al.  Web and database software for identification of intact proteins using "top down" mass spectrometry. , 2003, Analytical chemistry.

[89]  S. Atamas.  Alternative splice variants of cytokines: making a list. , 1997, Life sciences.

[90]  B. Blencowe.  Alternative Splicing: New Insights from Global Analyses , 2006, Cell.

[91]  Paul M Thomas,et al.  Robust analysis of the yeast proteome under 50 kDa by molecular-mass-based fractionation and top-down mass spectrometry. , 2012, Analytical chemistry.

[92]  Richard D. Smith,et al.  Proteomics by FTICR mass spectrometry: top down and bottom up. , 2005, Mass spectrometry reviews.

[93]  Christopher A. Blair,et al.  Potential molecular targeting of splice variants for cancer treatment. , 2011, Indian journal of experimental biology.

[94]  Neil L Kelleher,et al.  Precise and Parallel Characterization of Coding Polymorphisms, Alternative Splicing, and Modifications in Human Proteins by Mass Spectrometry*S , 2005, Molecular & Cellular Proteomics.

[95]  N. Kelleher,et al.  Quantitative analysis of modified proteins and their positional isomers by tandem mass spectrometry: human histone H4. , 2006, Analytical chemistry.

[96]  Christopher J. Robinson,et al.  The splice variants of vascular endothelial growth factor (VEGF) and their receptors. , 2001, Journal of cell science.

[97]  F. Clark,et al.  Understanding alternative splicing: towards a cellular code , 2005, Nature Reviews Molecular Cell Biology.

[98]  N. Kelleher,et al.  Intact mass detection, interpretation, and visualization to automate Top‐Down proteomics on a large scale , 2010, Proteomics.

[99]  E. Blackburn,et al.  Expression of neuregulin 4 splice variants in normal human tissues and prostate cancer and their effects on cell motility. , 2010, Endocrine-related cancer.

[100]  J. Fandrey,et al.  Thrombopoietin gene expression in the developing human central nervous system. , 2003, Brain research. Developmental brain research.

[101]  Serge Rudaz,et al.  Intact protein analysis in the biopharmaceutical field. , 2011, Journal of pharmaceutical and biomedical analysis.

[102]  G. Pagès,et al.  VEGF Spliced Variants: Possible Role of Anti-Angiogenesis Therapy , 2011, Journal of nucleic acids.

[103]  E. Kraynov,et al.  Identification and quantification of osteopontin splice variants in the plasma of lung cancer patients using immunoaffinity capture and targeted mass spectrometry , 2012, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[104]  A. Capriotti,et al.  Intact protein separation by chromatographic and/or electrophoretic techniques for top-down proteomics. , 2011, Journal of chromatography. A.

[105]  M. Moon,et al.  Chip-type asymmetrical flow field-flow fractionation channel coupled with mass spectrometry for top-down protein identification. , 2011, Analytical chemistry.